AXNX:NSD-Axonics Inc (USD)

COMMON STOCK | Medical Devices | NSD

Last Closing Price

USD 69.54

Change

-0.16 (-0.23)%

Market Cap

USD 3.22B

Volume

0.26M

Avg Analyst Target

USD 73.56 (+5.77%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, France, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is headquartered in Irvine, California.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-09-24 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ALGN Align Technology Inc

-1.87 (-0.26%)

USD56.71B 124.35 55.99
PODD Insulet Corporation

-1.40 (-0.48%)

USD20.01B 2,208.27 244.52
ABMD Abiomed Inc

-0.25 (-0.07%)

USD15.91B 103.67 53.06
LVGO Livongo Health, Inc

N/A

USD14.20B N/A N/A
BRKR Bruker Corporation

-0.29 (-0.34%)

USD12.64B 81.79 28.22
SWAV ShockWave Medical Inc

-5.12 (-2.25%)

USD8.00B N/A N/A
TNDM Tandem Diabetes Care Inc

-1.72 (-1.37%)

USD7.91B 1,218.35 239.94
INMD InMode Ltd

+5.43 (+3.17%)

USD6.53B 57.19 40.15
IART Integra LifeSciences Holdings ..

-0.15 (-0.21%)

USD6.12B 29.96 19.16
LIVN LivaNova PLC

-0.47 (-0.57%)

USD4.37B 77.40 N/A

ETFs Containing AXNX

Symbol Name Weight Mer Price(Change) Market Cap
XHE SPDR Series Trust - SPDR .. 0.00 % 0.35 %

-1.44 (-1.10%)

USD0.81B
UNIC:LSE Lyxor Index Fund - Lyxor .. 0.00 % 0.15 %

+0.11 (+0.64%)

N/A
DRUP:XETRA Lyxor Index Fund - Lyxor .. 0.00 % 0.45 %

-0.04 (-0.24%)

USD0.34B

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 39.30% 62% D- 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.30% 62% D- 81% B-
Trailing 12 Months  
Capital Gain 53.58% 51% F 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 53.58% 51% F 63% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 42.16% 68% D+ 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 42.16% 68% D+ 81% B-
Risk Return Profile  
Volatility (Standard Deviation) 44.99% 70% C- 41% F
Risk Adjusted Return 93.69% 98% A+ 91% A-
Market Capitalization 3.22B 89% B+ 81% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 6.30 35% F 23% F
Price / Cash Flow Ratio -38.44 80% B- 85% B
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -17.00% 59% F 41% F
Return on Invested Capital -21.01% 57% F 28% F
Return on Assets -7.23% 60% D- 31% F
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio 7.49 22% F 19% F
Short Percent 8.92% 15% F 19% F
Beta 0.07 94% A 94% A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.